Birmingham, West Midlands -- (SBWIRE) -- 12/27/2013 -- Value Penny Stocks issues special report on FuelCell Energy Inc (NASDAQ:FCEL), JDS Uniphase Corp (NASDAQ:JDSU), Idera Pharmaceuticals Inc (NASDAQ:IDRA), Novavax, Inc. (NASDAQ:NVAX).
FuelCell Energy Inc (NASDAQ:FCEL) ended its recent business day with the gain of 1.49% and closed at the price of $1.36 after opening at $1.34. The stock traded during its last trading session with the total volume of 3,148,312 shares, as compared to its average volume of 5.10 million shares. FuelCell Energy, Inc., together with its subsidiaries, designs, manufactures, sells, installs, operates, and services stationary fuel cell power plants for distributed baseload power generation. It offers Direct FuelCell power plants that electrochemically produce electricity and heat using various fuels, including gas, methanol, diesel, biogas, coal gas, coal mine methane, and propane.
For How Long FCEL will Fight for Profitability? Read This Trend Analysis report
JDS Uniphase Corp (NASDAQ:JDSU) remained among the day decliners and traded with volume of 3,066,434 shares in the last session, as compared to average volume of 5.42 million shares. In comparison with 52 week range of $11.70 - $16.61, it faced lowest price of $12.77 during the last trading session whereas its day highest price was $13.06. The company’s total market capitalization is $2.97 billion, along with 232.84 million shares outstanding. JDS Uniphase Corporation provides communications test and measurement solutions, and optical products for telecommunications service providers, wireless operators, cable operators, network-equipment manufacturers, original equipment manufacturers, enterprises, government organizations, distributors, and strategic partners worldwide.
Has JDSU Found The Bottom And Ready To Gain Momentum? Find Out Here
Idera Pharmaceuticals Inc (NASDAQ:IDRA) showed 3,021,174 shares in volume during the last trading session, while the average trading volume remained 1.37 million shares. The stock kicked off its trading session at $3.39 and closed at $3.73 after mounting 10.03%. Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, engages in the discovery and development of novel synthetic DNA- and RNA- based drug candidates. It is developing drug candidates designed to modulate immune responses mediated through Toll-like Receptors (TLRs).
Will IDRA Continue To Move Higher? Find Out Here
Novavax, Inc. (NASDAQ:NVAX) stock traded during its last trading session with the total traded volume of 2,898,335 shares versus its average volume of 5.71 million shares. The company opened its trade at the price of $5.15 and its closing price was $5.13 after gaining 0.98% for the day. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company’s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines.
Why Should Investors Buy NVAX After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)